饮食维生素B1摄入量与老年患者中风风险之间的关联:一项回顾性横截面研究
Shitu Zhuo1, Zhenjie Chen2, Lichao Ye1
1Department of Neurology, The Second Affiliated Hospital of Fujian Medical University, 34 Zhongshan North Road, Licheng District, Quanzhou City, 362000, Fujian Province, China.
BMC neurology
|August 5, 2025
概括
适当的维生素B1 (胺) 摄入量可能会降低老年人中风风险. 较低的食胺水平与更高的中风风险有关,这表明它在预防策略中的重要性.
科学领域:
- 营养流行病学 营养流行病学
- 心血管健康 心血管健康
- 老年医学 老年医学
背景情况:
- 脑卒中风险与B族维生素有关,但对维生素B1 (胺) 的数据有限.
- 这项研究探讨了美国成年人饮食中胺摄入量与中风风险之间的关联.
研究的目的:
- 检查饮食维生素B1摄入量与中风风险之间的相关性.
- 提供证据证明胺在老年人群中卒中预防中的作用.
主要方法:
- 对国家健康和营养检查调查 (NHANES) 数据 (2003-2018) 的回顾性分析.
- 包括11724名60岁及以上的美国成年人.
- 使用后勤回归,限制立方线和灵敏度分析.
主要成果:
- 与中风患者相比,在没有中风的个体中,食维生素B1水平显著更高 (p < 0.001).
- 在完全调整后,发现了维生素B1摄入量与中风风险 (OR=0.63,95% CI:0.48-0.83) 之间的反作用关联.
- 饮食中提氨酸摄入量每增加1个单位,就与中风风险降低37%相关.
结论:
- 饮食中较低的维生素B1摄入量与老年人中风风险增加有关.
- 适当的胺摄入量可能是老龄化人口中风预防策略的关键因素.
相关概念视频
Vitamins
992
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
992
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
420
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420
Atherosclerosis IV: Nursing Management
51
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
51
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35


